Mimedx Group Inc (MDXG)

$9.12 +0.04 (0.44%)
Market Cap 1.33B
Revenue (ttm) 321.48M
Net Income (ttm) 58.23M
EPS (ttm) N/A
PE Ratio 33.12
Forward PE 28.70
Profit Margin 18.11%
Debt to Equity Ratio 0.01
Volume 518,800
Avg Vol 906,652
Day's Range N/A - N/A
Shares Out 146.95M
Stochastic %K 26%
Beta 1.96
Analysts Strong Sell
Price Target $13.00

Latest News on MDXG

MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs

Nov 14, 2024, 9:15 AM EST - 2 months ago

MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDs

MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 9:38 PM EDT - 2 months ago

MiMedx Group, Inc. (MDXG) Q3 2024 Earnings Call Transcript

MIMEDX Announces Third Quarter 2024 Operating and Financial Results

Oct 30, 2024, 4:01 PM EDT - 2 months ago

MIMEDX Announces Third Quarter 2024 Operating and Financial Results

MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

Oct 14, 2024, 8:00 AM EDT - 3 months ago

MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30

MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue

Oct 8, 2024, 4:01 PM EDT - 3 months ago

MIMEDX Points to The New York Times Article on the Vast Benefits of Placental Tissue

MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall

Oct 1, 2024, 4:01 PM EDT - 3 months ago

MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC Fall

EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"

Sep 11, 2024, 1:03 PM EDT - 4 months ago

EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"

THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'

Sep 4, 2024, 4:23 PM EDT - 4 months ago

THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'

DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT

Aug 26, 2024, 9:30 AM EDT - 5 months ago

DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT

MiMedx Group, Inc. (MDXG) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 9:10 PM EDT - 6 months ago

MiMedx Group, Inc. (MDXG) Q2 2024 Earnings Call Transcript

MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix

Jul 31, 2024, 4:02 PM EDT - 6 months ago

MIMEDX Announces Launch of HELIOGEN™ Fibrillar Collagen Matrix

MIMEDX Announces Second Quarter 2024 Operating and Financial Results

Jul 31, 2024, 4:01 PM EDT - 6 months ago

MIMEDX Announces Second Quarter 2024 Operating and Financial Results

MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports

Jul 22, 2024, 8:10 AM EDT - 6 months ago

MIMEDX Announces Publication Focused on Surgical Applications Using MIMEDX Placental-Based Allografts in Nature – Scientific Reports

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

Jun 26, 2024, 4:01 PM EDT - 7 months ago

MIMEDX Announces the Appointment of Kim Moller to Chief Commercial Officer

MIMEDX to Participate in Upcoming Investor Conferences

May 15, 2024, 8:00 AM EDT - 8 months ago

MIMEDX to Participate in Upcoming Investor Conferences

MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript

Apr 30, 2024, 9:33 PM EDT - 9 months ago

MiMedx Group, Inc. (MDXG) Q1 2024 Earnings Call Transcript

MIMEDX Announces First Quarter 2024 Operating and Financial Results

Apr 30, 2024, 4:01 PM EDT - 9 months ago

MIMEDX Announces First Quarter 2024 Operating and Financial Results

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

Apr 16, 2024, 8:00 AM EDT - 9 months ago

MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

Mar 20, 2024, 7:00 AM EDT - 10 months ago

MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing

MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 8:46 PM EST - 11 months ago

MiMedx Group, Inc. (MDXG) Q4 2023 Earnings Call Transcript

MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

Feb 28, 2024, 4:01 PM EST - 11 months ago

MIMEDX Announces Fourth Quarter and Full Year 2023 Operating and Financial Results

MIMEDX to Present at TD Cowen 44th Annual Health Care Conference

Feb 20, 2024, 8:00 AM EST - 11 months ago

MIMEDX to Present at TD Cowen 44th Annual Health Care Conference

MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28

Feb 12, 2024, 8:00 AM EST - 1 year ago

MIMEDX to Host Fourth Quarter and Full Year 2023 Operating and Financial Results Conference Call on February 28

MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing

Jan 22, 2024, 8:00 AM EST - 1 year ago

MIMEDX Announces Improved Capital Structure with New Senior Secured Credit Facilities and Debt Refinancing

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

Jan 12, 2024, 4:00 PM EST - 1 year ago

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

The Law Offices of Frank R. Cruz Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

Jan 11, 2024, 12:54 PM EST - 1 year ago

The Law Offices of Frank R. Cruz Announces Investigation of MiMedx Group, Inc. (MDXG) on Behalf of Investors

MiMedx reports US FDA warning letter for Axiofill, shares drop

Dec 29, 2023, 7:01 PM EST - 1 year ago

MiMedx reports US FDA warning letter for Axiofill, shares drop

MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook

Dec 29, 2023, 5:00 PM EST - 1 year ago

MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook

MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock

Dec 28, 2023, 8:00 AM EST - 1 year ago

MIMEDX Announces Conversion of Outstanding Series B Convertible Preferred Stock to Common Stock

MIMEDX to Highlight Published Data at SAWC Fall

Nov 2, 2023, 8:00 AM EDT - 1 year ago

MIMEDX to Highlight Published Data at SAWC Fall

MiMedx Group, Inc. (MDXG) Q3 2023 Earnings Call Transcript

Oct 30, 2023, 9:17 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q3 2023 Earnings Call Transcript

MIMEDX Announces Third Quarter 2023 Operating and Financial Results

Oct 30, 2023, 4:01 PM EDT - 1 year ago

MIMEDX Announces Third Quarter 2023 Operating and Financial Results

MiMedx Group, Inc. (MDXG) Q2 2023 Earnings Call Transcript

Aug 1, 2023, 6:48 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q2 2023 Earnings Call Transcript

MIMEDX Announces Second Quarter 2023 Operating and Financial Results

Aug 1, 2023, 4:01 PM EDT - 1 year ago

MIMEDX Announces Second Quarter 2023 Operating and Financial Results

MIMEDX to Host Second Quarter 2023 Operating and Financial Results Conference Call on August 1

Jul 18, 2023, 8:00 AM EDT - 1 year ago

MIMEDX to Host Second Quarter 2023 Operating and Financial Results Conference Call on August 1

MIMEDX Appoints Doug Rice as Chief Financial Officer

Jul 5, 2023, 8:00 AM EDT - 1 year ago

MIMEDX Appoints Doug Rice as Chief Financial Officer

MIMEDX Announces Strategic Realignment: Increases Focus on Wound & Surgical Business, Expected to Significantly Improve Profitability

Jun 20, 2023, 4:01 PM EDT - 1 year ago

MIMEDX Announces Strategic Realignment: Increases Focus on Wound & Surgical Business, Expected to Significantly Improve Profitability

MiMedx Group, Inc. (MDXG) Q1 2023 Earnings Call Transcript

May 2, 2023, 11:08 PM EDT - 1 year ago

MiMedx Group, Inc. (MDXG) Q1 2023 Earnings Call Transcript

MIMEDX Announces First Quarter 2023 Operating and Financial Results

May 2, 2023, 4:01 PM EDT - 1 year ago

MIMEDX Announces First Quarter 2023 Operating and Financial Results

MIMEDX to Host First Quarter 2023 Operating and Financial Results Conference Call on May 2

Apr 18, 2023, 8:00 AM EDT - 1 year ago

MIMEDX to Host First Quarter 2023 Operating and Financial Results Conference Call on May 2

MIMEDX Announces Chief Financial Officer Transition

Mar 23, 2023, 4:01 PM EDT - 1 year ago

MIMEDX Announces Chief Financial Officer Transition

MIMEDX Comments on Recent Data Brief Published by Office of Inspector General

Mar 16, 2023, 8:00 AM EDT - 2 years ago

MIMEDX Comments on Recent Data Brief Published by Office of Inspector General

MiMedx Group, Inc. (MDXG) Q4 2022 Earnings Call Transcript

Feb 28, 2023, 10:46 PM EST - 2 years ago

MiMedx Group, Inc. (MDXG) Q4 2022 Earnings Call Transcript

MIMEDX Announces Fourth Quarter and Full Year 2022 Operating and Financial Results

Feb 28, 2023, 4:01 PM EST - 2 years ago

MIMEDX Announces Fourth Quarter and Full Year 2022 Operating and Financial Results

MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director

Jan 30, 2023, 8:00 AM EST - 2 years ago

MIMEDX Appoints Joseph H. Capper as Chief Executive Officer and Director

MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations, Comments on Evolving Medicare Reimbursement Landscape and Provides Corporate Updates

Jan 9, 2023, 8:02 AM EST - 2 years ago

MIMEDX Confirms Fourth Quarter and Full Year 2022 Net Sales Expectations, Comments on Evolving Medicare Reimbursement Landscape and Provides Corporate Updates

MIMEDX Announces Commercial Launch of EPIFIX® in Japan with Exclusive Distribution Agreement with GUNZE MEDICAL LIMITED

Jan 4, 2023, 4:01 PM EST - 2 years ago

MIMEDX Announces Commercial Launch of EPIFIX® in Japan with Exclusive Distribution Agreement with GUNZE MEDICAL LIMITED

MiMedx Group, Inc. (MDXG) Q3 2022 Earnings Call Transcript

Nov 2, 2022, 10:32 PM EDT - 2 years ago

MiMedx Group, Inc. (MDXG) Q3 2022 Earnings Call Transcript